Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25644938 | 0.86 | HTR2C (0.41) | ADRA2AADRA1AMAPTBLMMGLL | |
| SCHEMBL14990807 | 0.85 | ADRA2A (0.48) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL14191480 | 0.83 | DGKA (0.45) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL475320 | 0.82 | ADRA2A (0.52) | ADRA2AADRA1AMAPTBLMMGLL | |
| SCHEMBL2701641 | 0.82 | CYP19A1 (0.44) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL25579770 | 0.82 | ADRA2A (0.42) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL29309550 | 0.80 | ADRA2A (0.73) | ADRA2AADRA1AMAPTBLMTSHR | |
| SCHEMBL12873361 | 0.79 | TSHR (0.48) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL4388016 | 0.78 | CYP1A2 (0.48) | MAPTTSHRALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL15141277 | 0.78 | ADRA2A (0.38) | ADRA2AADRA1AMAPTBLMMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3126424-B1 | ALIPHATIC POLYCARBONATE POLYOL COMPOSITIONS | SAUDI ARAMCO TECH CO (SA) | 2020-09-30 | — | — | EP | disclosed |
| US-20160206588-A1 | STABILIZED FORMULATIONS OF FATTY ACIDS | MYCELL TECHNOLOGIES LLC (US) | 2016-07-21 | — | — | US | disclosed |
| US-20150164843-A1 | STABILIZED FORMULATIONS OF FATTY ACIDS | MYCELL TECHNOLOGIES LLC (US) | 2015-06-18 | — | — | US | disclosed |
| US-8927043-B2 | Stabilized formulations of fatty acids | Mycell Technologies (US) | 2015-01-06 | — | — | US | disclosed |
| US-20140039052-A1 | FORMULATIONS OF LIPOPHILIC BIOACTIVE MOLECULES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2014-02-06 | — | — | US | disclosed |
| US-20120088829-A1 | Formulations of Ubiquinol and Resveratrol Esters | MyCell Holdings Limited | 2012-04-12 | — | — | US | disclosed |
| US-20110118351-A1 | Stabilized Formulations of Fatty Acids | MyCell Holdings Limited | 2011-05-19 | — | — | US | disclosed |
| US-7887835-B2 | for vascular lesion imaging and for diagnosing arteriosclerosis, ischemia with X-ray angiography and positron emission tomography; fluorinated steroid ester, glyceride compounds, phosphatidylcholine, and phosphatidylserine as membrane components of liposome | FUJIFILM CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-20100279413-A1 | APPLICATIONS OF UBIQUINONES AND UBIQUINOLS | ZYMES, LLC | 2010-11-04 | — | — | US | disclosed |
| US-20100080785-A1 | DRIED FORMULATIONS | ZYMES, LLC (US) | 2010-04-01 | — | — | US | disclosed |
| US-20080254188-A1 | Storage stability; contains water soluble reducing agent preventing chemical degradation; contains solubilizing agent such as polyoxyethylene glycol with dibasic acid linked sterol, tocopherol and/or ubiquinol; beverages | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2008-10-16 | — | — | US | disclosed |
| US-20080138285-A1 | Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound | FUJIFILM CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080138285-A1 | Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound | PHOSPHO1, SGMS1, SGMS2 | ADRA2A 1638/4885ADRA1A 1544/4885MAPT 3322/4885 |
| US-20110118351-A1 | Stabilized Formulations of Fatty Acids | FABP4, FABP2, FABP1 | ADRA2A 3978/4885ADRA1A 4088/4885MAPT 1953/4885 |
| US-20100080785-A1 | DRIED FORMULATIONS | NDUFV3, NDUFA3, NDUFAF3 | ADRA2A 4207/4885ADRA1A 4154/4885MAPT 3382/4885 |
| US-20150164843-A1 | STABILIZED FORMULATIONS OF FATTY ACIDS | FABP4, FABP2, FABP1 | ADRA2A 3978/4885ADRA1A 4088/4885MAPT 1953/4885 |
| US-20120088829-A1 | Formulations of Ubiquinol and Resveratrol Esters | COQ8A, COQ8B, NDUFA8 | ADRA2A 4611/4885ADRA1A 4543/4885MAPT 940/4885 |
| US-20140039052-A1 | FORMULATIONS OF LIPOPHILIC BIOACTIVE MOLECULES | LIPA, LIPC, CEL | ADRA2A 3295/4885ADRA1A 3247/4885MAPT 3844/4885 |
| US-20160206588-A1 | STABILIZED FORMULATIONS OF FATTY ACIDS | FABP4, FABP2, FABP1 | ADRA2A 3978/4885ADRA1A 4088/4885MAPT 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.